Sandra Franco
Universidad El Bosque(CO)Foundation for Clinical and Applied Cancer Research(CO)
Publications by Year
Research Areas
Hepatitis C virus research, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, HIV Research and Treatment, Advanced Breast Cancer Therapies
Most-Cited Works
- → Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study(2020)865 cited
- → Efficacy and Safety of Lapatinib As First-Line Therapy for ErbB2-Amplified Locally Advanced or Metastatic Breast Cancer(2008)340 cited
- → A phase II study of lapatinib monotherapy in chemotherapy-refractory HER2-positive and HER2-negative advanced or metastatic breast cancer(2008)205 cited
- → Lapatinib plus Letrozole as First-Line Therapy for HER-2+ Hormone Receptor–Positive Metastatic Breast Cancer(2010)189 cited
- → Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents(2016)112 cited
- → Therapy Implications of Hepatitis C Virus Genetic Diversity(2020)105 cited